OpenURL Connection Search

Select item for more details and to access through your institution.

Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement.
Published in:
Annals of Hematology, 2024, v. 103, n. 4, p. 1421, doi. 10.1007/s00277-023-05599-3
By:
- Martino, Giovanni;
- Cimino, Gaetano;
- Caridi, Matteo;
- Perta, Giuseppe;
- Cardinali, Valeria;
- Sciabolacci, Sofia;
- Quintini, Martina;
- Matteucci, Caterina;
- Venanzi, Alessandra;
- Tiacci, Enrico;
- Ascani, Stefano;
- Cristina Mecucci;
- Martelli, Maria Paola
Publication type:
Article
One disease, two faces: clonally-related AML and MPDCP with skin involvement.
Published in:
Annals of Hematology, 2023, v. 102, n. 10, p. 2969, doi. 10.1007/s00277-023-05377-1
By:
- Martino, Giovanni;
- Cimino, Gaetano;
- Caridi, Matteo;
- Perta, Giuseppe;
- Cardinali, Valeria;
- Sciabolacci, Sofia;
- Quintini, Martina;
- Matteucci, Caterina;
- Ascani, Stefano;
- Mecucci, Cristina;
- Martelli, Maria Paola
Publication type:
Article
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs).
Published in:
Cancers, 2024, v. 16, n. 15, p. 2675, doi. 10.3390/cancers16152675
By:
- Pierangeli, Sara;
- Donnini, Serena;
- Ciaurro, Valerio;
- Milano, Francesca;
- Cardinali, Valeria;
- Sciabolacci, Sofia;
- Cimino, Gaetano;
- Gionfriddo, Ilaria;
- Ranieri, Roberta;
- Cipriani, Sabrina;
- Padiglioni, Eleonora;
- Iacucci Ostini, Roberta;
- Zei, Tiziana;
- Pierini, Antonio;
- Martelli, Maria Paola
Publication type:
Article
Prescription patterns of venetoclax in acute myeloid leukemia.
Published in:
Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3298
By:
- Ucciero, Andrealuna;
- Traversa, Giuseppe;
- Pisterna, Alessia;
- Cardinali, Valeria;
- Sciabolacci, Sofia;
- Poloni, Antonella;
- Capelli, Debora;
- Gaidano, Gianluca;
- Patriarca, Andrea;
- Lunghi, Monia
Publication type:
Article
Blinatumomab Redirects Donor Lymphocytes against CD19 + Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 22, p. 16105, doi. 10.3390/ijms242216105
By:
- Mancusi, Antonella;
- Zorutti, Francesco;
- Ruggeri, Loredana;
- Bonato, Samanta;
- Tricarico, Sara;
- Zei, Tiziana;
- Iacucci Ostini, Roberta;
- Viglione, Valerio;
- Sembenico, Rebecca;
- Sciabolacci, Sofia;
- Cardinali, Valeria;
- Martelli, Massimo Fabrizio;
- Mecucci, Cristina;
- Carotti, Alessandra;
- Martelli, Maria Paola;
- Velardi, Andrea;
- Pierini, Antonio
Publication type:
Article

Found: 5

Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement.

One disease, two faces: clonally-related AML and MPDCP with skin involvement.

The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs).

Prescription patterns of venetoclax in acute myeloid leukemia.

Blinatumomab Redirects Donor Lymphocytes against CD19 + Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation.